(Q54480779)

30 May 2018

title

The prognostic role of TGF-β signaling pathway in breast cancer patients. (English)

1 reference

30 May 2018

author name string

E M de Kruijf

1

1 reference

30 May 2018

T J A Dekker

2

1 reference

30 May 2018

L J A C Hawinkels

3

1 reference

30 May 2018

H Putter

4

1 reference

30 May 2018

V T H B M Smit

5

1 reference

30 May 2018

J R Kroep

6

1 reference

30 May 2018

P J K Kuppen

7

1 reference

30 May 2018

C J H van de Velde

8

1 reference

30 May 2018

P ten Dijke

9

1 reference

30 May 2018

R A E M Tollenaar

10

1 reference

30 May 2018

W E Mesker

11

1 reference

30 May 2018

publication date

28 September 2012

1 reference

30 May 2018

published in

Annals of Oncology

1 reference

30 May 2018

volume

24

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

384-390

1 reference

30 May 2018

TGF-beta in mammary development and neoplasia.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Determination of TGFbeta1 protein level in human primary breast cancers and its relationship with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

A structural basis for mutational inactivation of the tumour suppressor Smad4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Smad4-expression is decreased in breast cancer tissues: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Non-Smad pathways in TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

PARP-1 attenuates Smad-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS333

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS333

1 reference

30 May 2018

PubMed ID

23022998

1 reference

30 May 2018